Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%
Ph phase_3
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(2)
Other(2)

Detailed Status

Completed2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (33.3%)
N/A2 (66.7%)

Trials by Status

completed250%
unknown250%

Recent Activity

0 active trials
Showing 4 of 4
completed

Using End-Tidal CO₂ to Help Diagnose and Monitor Pulmonary Embolism

NCT07241130
unknownnot_applicable

Thrombolytic Therapy Versus Surgery for Obstructive Prosthetic Valve Thrombosis

NCT02243839
completedphase_3

Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

NCT00000552
unknownnot_applicable

Senior PAMI: Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly

NCT00136929

Clinical Trials (4)

Showing 4 of 4 trials
NCT07241130

Using End-Tidal CO₂ to Help Diagnose and Monitor Pulmonary Embolism

Completed
NCT02243839Not Applicable

Thrombolytic Therapy Versus Surgery for Obstructive Prosthetic Valve Thrombosis

Unknown
NCT00000552Phase 3

Shock Trial: Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

Completed
NCT00136929Not Applicable

Senior PAMI: Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly

Unknown

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4